The National Institute on Aging and the Alzheimer’s Association charged a workgroup with
the task of revising the 1984 criteria for Alzheimer’s disease (AD) dementia. The workgroup …

In 2011, the National Institute on Aging and Alzheimer's Association created separate diagnostic
recommendations for the preclinical, mild cognitive impairment, and dementia stages of …

Scientific evidence continues to demonstrate the linkage of vascular contributions to
cognitive impairment and dementia such as Alzheimer's disease. In December, 2013, the …

The National Institute on Aging and the Alzheimer’s Association charged a workgroup with
the task of developing criteria for the symptomatic predementia phase of Alzheimer’s disease (…

The pathophysiological process of Alzheimer’s disease (AD) is thought to begin many years
before the diagnosis of AD dementia. This long “preclinical” phase of AD would provide a …

A consensus panel from the United States and Europe was convened recently to update
and revise the 1997 consensus guidelines for the neuropathologic evaluation of Alzheimer's …

BACKGROUND: Criteria for the clinical diagnosis of Alzheimer's disease (AD) were
established in 1984. A broad consensus now exists that these criteria should be revised to …

During the past decade, a conceptual shift occurred in the field of Alzheimer's disease (AD)
considering the disease as a continuum. Thanks to evolving biomarker research and …

An estimated 47 million people worldwide are living with dementia in 2015, and this number
is projected to triple by 2050. In the absence of a disease-modifying treatment or cure, …

Biomarkers have become an essential component of Alzheimer disease (AD) research and
because of the pervasiveness of AD pathology in the elderly, the same biomarkers are used …